Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Nausea × Olanzapine × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 2 Other hematologic neoplasm 1 Head & Neck 1 Genitourinary 1 Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2 Vomiting 1 Radiation Injuries 1 Nausea 1

Interventions

Palonosetron 2 fosaprepitant 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiotherapy 1 Olanzapine 1 Electroacupuncture 1 Dexamethasone 1 Cisplatin 1 Calcium Dobesilate 1 Aprepitant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05202275 2022-01-21

The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs

ChineseAMS

Phase 2 Unknown

Squamous Cell Carcinoma of Head and Neck, Nausea, Radiation Injuries, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡